336 related articles for article (PubMed ID: 29462222)
1. Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity.
Harper J; Del Rosso JQ; Ferrusi IL
J Drugs Dermatol; 2018 Feb; 17(2):150-158. PubMed ID: 29462222
[TBL] [Abstract][Full Text] [Related]
2. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
[TBL] [Abstract][Full Text] [Related]
3. Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society.
Baldwin HE; Harper J; Baradaran S; Patel V
Dermatol Ther (Heidelb); 2019 Dec; 9(4):725-734. PubMed ID: 31512178
[TBL] [Abstract][Full Text] [Related]
4. The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.
Del Rosso JQ; Tanghetti EA; Baldwin HE; Rodriguez DA; Ferrusi IL
J Clin Aesthet Dermatol; 2017 Jun; 10(6):17-31. PubMed ID: 28979654
[No Abstract] [Full Text] [Related]
5. Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.
Zeichner JA; Eichenfield LF; Feldman SR; Kasteler JS; Ferrusi IL
J Clin Aesthet Dermatol; 2018 Feb; 11(2):47-52. PubMed ID: 29552276
[No Abstract] [Full Text] [Related]
6. Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
Kuang AW; DuBois J; Attar M; Ahluwalia G
J Drugs Dermatol; 2018 Feb; 17(2):213-220. PubMed ID: 29462230
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
DuBois J; Dover JS; Jones TM; Weiss RA; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Mar; 17(3):308-316. PubMed ID: 29537449
[TBL] [Abstract][Full Text] [Related]
8. Facial flushing and erythema of rosacea improved by carvedilol.
Seo BH; Kim DH; Suh HS; Choi YS
Dermatol Ther; 2020 Nov; 33(6):e14520. PubMed ID: 33174351
[TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic Rosacea.
Schlessinger J; Lupin M; McDaniel D; George R
J Drugs Dermatol; 2019 Jun; 18(6):522. PubMed ID: 31251544
[TBL] [Abstract][Full Text] [Related]
10. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
[TBL] [Abstract][Full Text] [Related]
11. [Quality of life in patients with rosacea].
Salamon M; Chodkiewicz J; Sysa-Jedrzejowska A; Wozniacka A
Przegl Lek; 2008; 65(9):385-9. PubMed ID: 19140386
[TBL] [Abstract][Full Text] [Related]
12. Rosacea: Diagnosis and Treatment.
Oge' LK; Muncie HL; Phillips-Savoy AR
Am Fam Physician; 2015 Aug; 92(3):187-96. PubMed ID: 26280139
[TBL] [Abstract][Full Text] [Related]
13. Clinical, Histologic, and Molecular Analysis of Differences Between Erythematotelangiectatic Rosacea and Telangiectatic Photoaging.
Helfrich YR; Maier LE; Cui Y; Fisher GJ; Chubb H; Fligiel S; Sachs D; Varani J; Voorhees J
JAMA Dermatol; 2015 Aug; 151(8):825-36. PubMed ID: 25798811
[TBL] [Abstract][Full Text] [Related]
14. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
Tanghetti EA; Dover JS; Goldberg DJ; Dhawan SS; Luo L; Berk DR; Ahluwalia G; Alvandi N
J Drugs Dermatol; 2018 Jun; 17(6):621-626. PubMed ID: 29879249
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of 234 rosacea patients according to clinical subtype: The significance of central facial erythema in the prognosis of rosacea.
Lee WJ; Lee YJ; Lee MH; Won CH; Chang SE; Choi JH; Lee MW
J Dermatol; 2016 May; 43(5):526-31. PubMed ID: 26507367
[TBL] [Abstract][Full Text] [Related]
16. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
[TBL] [Abstract][Full Text] [Related]
17. Self-reported treatment impressions and satisfaction of papulopustular rosacea patients treated with doxycycline, USP, 40 mg capsules.
Johnson SM; LeVine P
J Drugs Dermatol; 2011 Dec; 10(12):1376-81. PubMed ID: 22134561
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of rosacea in an Estonian working population using a standard classification.
Abram K; Silm H; Oona M
Acta Derm Venereol; 2010 May; 90(3):269-73. PubMed ID: 20526544
[TBL] [Abstract][Full Text] [Related]
19. Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.
Draelos ZD; Gunt H; Levy SB
J Drugs Dermatol; 2019 Feb; 18(2):141-146. PubMed ID: 30794364
[TBL] [Abstract][Full Text] [Related]
20. Blushing propensity and psychological distress in people with rosacea.
Su D; Drummond PD
Clin Psychol Psychother; 2012; 19(6):488-95. PubMed ID: 21698719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
